Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 Histological scores for cartilage repair at 1 month and 3 months after surgerya

From: Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair

  1 month 3 months
  Group B Control Group B Control
Ti 3.77 ± 0.4 3.20 ± 0.7 3.85 ± 0.3* 2.10 ± 1.4
Matx 3.55 ± 0.7 3.30 ± 0.8 3.71 ± 0.7* 2.10 ± 1.4
Stru 3.66 ± 0.5 3.00 ± 0.8 4.28 ± 0.7* 2.41 ± 1.6
Clus 2.88 ± 0.3 2.90 ± 0.3 3.00 ± 0.0* 1.60 ± 0.8
Tide 1.00 ± 0.0 1.00 ± 0.0 3.85 ± 1.4 2.20 ± 1.6
Bform 1.66 ± 0.7 1.20 ± 0.4 2.85 ± 0.3 2.90 ± 0.3
SurfH 3.55 ± 0.5* 2.70 ± 0.8 3.71 ± 0.4* 1.70 ± 1.0
FilH 4.66 ± 0.5* 3.70 ± 1.0 5.00 ± 0.0* 2.90 ± 1.9
Latl 2.77 ± 0.4* 1.80 ± 0.6 2.85 ± 0.3* 1.60 ± 0.8
Basl 4.00 ± 0.0 4.00 ± 0.0 4.00 ± 0.0 4.00 ± 0.0
InfH 5.00 ± 0.0 3.80 ± 1.3 5.00 ± 0.0 5.00 ± 0.0
Hgtot 36.55 ± 2.1* 30.50 ± 4.1 40.14 ± 2.5* 27.7 ± 10.0
  1. aValues are means ± SD. The total score range is from 11 (no repair) to 45 (normal articular cartilage).
  2. *Denotes significance at P < 0.05.